Nuzenio

Refractory Melanoma

Refractory Melanoma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Replimune to ride wave of physician support to launch advanced melanoma therapy - BioSpaceBioSpace · Fri, 07 Aug 2026 14:28:05 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLivePharmaLive · Fri, 07 Aug 2026 13:02:22 GMTFDA Approves New Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - finchannelfinchannel · Fri, 07 Aug 2026 12:56:58 GMTFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 20:45:00 GMTFDA advisory committee backs RP1 efficacy in anti-PD-1–refractory advanced melanoma - AllSciAllSci · Fri, 31 Jul 2026 12:34:55 GMTReplimune surges after FDA advisers back skin cancer drug - 95 KQDS95 KQDS · Fri, 31 Jul 2026 11:16:53 GMTDiakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma - markets.businessinsider.commarkets.businessinsider.com · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 14:28:05 GMTReplimune to ride wave of physician support to launch advanced melanoma therapy - BioSpace
Fri, 07 Aug 2026 13:02:22 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLive
Fri, 07 Aug 2026 12:56:58 GMTFDA Approves New Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - finchannel
Thu, 06 Aug 2026 20:45:00 GMTFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma - Yahoo Finance Singapore
Fri, 31 Jul 2026 12:34:55 GMTFDA advisory committee backs RP1 efficacy in anti-PD-1–refractory advanced melanoma - AllSci
Fri, 31 Jul 2026 11:16:53 GMTReplimune surges after FDA advisers back skin cancer drug - 95 KQDS

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Refractory Melanoma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.